<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01921361</url>
  </required_header>
  <id_info>
    <org_study_id>B.30.2.ERC.0.01.00.01/27</org_study_id>
    <nct_id>NCT01921361</nct_id>
  </id_info>
  <brief_title>The Effects of Dexmedetomidine on Peroperative Shivering Incidence Under Spinal Anesthesia</brief_title>
  <official_title>The Effects of Dexmedetomidine on Peroperative Shivering Incidence Under Spinal Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TC Erciyes University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TC Erciyes University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study to compare the efficacy of intravenous or intrathecal
      dexmedetomidine on the incidence of shivering on patients who scheduled spinal anesthesia for
      elective surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The design of the study includes three study groups done in random order. The groups are as
      follows: 1) Control group received 15 mg levobupivacaine intrathecally and intravenous 0.9%
      sodium chloride; 2) Intravenous group received 15 mg levobupivacaine intrathecally and
      intravenous dexmedetomidine (1mcg/kg/10min, 0.5mcg/kg/h infusion) ; 3) Intrathecal group
      received 15 mg levobupivacaine + 3 mcg dexmedetomidine intrathecally and intravenous 0.9%
      sodium chloride.

      Throughout the study period,shivering scores, tympanic temperature were recorded, heart rate
      were measured continuously using an electrocardiogram; blood pressure was determined
      oscillometrically at 5 min intervals at the ankle. In case heart rate decreased by more than
      30% of the baseline atropin received and blood pressure decreased 30% of the baseline
      effedrin received.

      Side effects (bradycardia, hypotension, hypothermia, nausea and vomiting etc ) were recorded
      peroperatively in the operating room and postanesthetic care unit.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>shivering score</measure>
    <time_frame>1 day (From start of anaesthesia till discharge from the recovery room )</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>1 day (From start of anaesthesia till discharge from the recovery room )</time_frame>
    <description>non invasive blood pressure measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>1 day (From start of anaesthesia till discharge from the recovery room )</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>core temperature</measure>
    <time_frame>1 day (From start of anaesthesia till discharge from the recovery room )</time_frame>
    <description>lower than 36 celsius degree was accepted as hypothermia</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Perioperative/Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>Intravenous</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intrathecal (3 ml) 15 mg levobupivacaine + 0.3 ml 0.9% Sodium chloride and intravenous dexmedetomidine (dexmedetomidine diluted 1mcg/ml and than 1ml/kg/10 minutes and 0.5 ml/kg/hour infusion)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intrathecal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intrathecal (3 ml) 15 mg levobupivacaine + (0.3 ml) 3 mcg dexmedetomidine (dexmedetomidine diluted 10 mcg/ml) and intravenous 0.9% Sodium chloride (1ml/kg/10 minutes and 0.5 ml/kg/hour infusion)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intrathecal (3 ml) 15 mg levobupivacaine + 0.3 ml 0.9% Sodium chloride and intravenous 0.9% Sodium chloride (1ml/kg/10 minutes and 0.5 ml/kg/hour infusion).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine</intervention_name>
    <description>Intrathecal 3ml (15 mg)</description>
    <arm_group_label>Intravenous</arm_group_label>
    <arm_group_label>Intrathecal</arm_group_label>
    <arm_group_label>Control</arm_group_label>
    <other_name>Chirocaine, 0.5%, 10 ml, Abbott</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Intrathecal 3 microgram (diluted 1/10, 0.3 ml)</description>
    <arm_group_label>Intravenous</arm_group_label>
    <other_name>Precedex, 100 mcg/ml, Abbott</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Intravenous 1ml/kg/10 minutes and than 0.5 ml/kg/hour infusion (dexmedetomidine diluted 1 microgram/ml)</description>
    <arm_group_label>Intrathecal</arm_group_label>
    <other_name>Precedex, 100 mcg/ml, Abbott</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium chloride</intervention_name>
    <description>Intravenous 1ml/kg/10 minutes and than 0.5 ml/kg/hour infusion in the control and intrathecal groups, intrathecal 0.3 ml in the control and intravenous groups.</description>
    <arm_group_label>Intravenous</arm_group_label>
    <arm_group_label>Intrathecal</arm_group_label>
    <arm_group_label>Control</arm_group_label>
    <other_name>0.9 Sodium chloride</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-65 y/o patients

          -  American Society of Anesthesiologists' physical status class I-II

          -  Scheduled for the spinal anesthesia

        Exclusion Criteria:

          -  Patients who have the body temperature over 37.3 celsius degree

          -  Pregnants

          -  Known allergies to the study drugs

          -  Contraindication to spinal anesthesia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Resul Altuntas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>TC Erciyes University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Erciyes University</name>
      <address>
        <city>Kayseri</city>
        <zip>38039</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2013</study_first_submitted>
  <study_first_submitted_qc>August 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2013</study_first_posted>
  <last_update_submitted>August 12, 2013</last_update_submitted>
  <last_update_submitted_qc>August 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>TC Erciyes University</investigator_affiliation>
    <investigator_full_name>RESUL ALTUNTAS</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Shivering</keyword>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Spinal anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

